Literature DB >> 24595616

Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings.

Enrique Coss-Adame1, Satish S C Rao.   

Abstract

Irritable bowel syndrome (IBS) is characterized by abdominal pain and altered bowel habits. Visceral hypersensitivity is believed to be a key underlying mechanism that causes pain. There is evidence that interactions within the brain and gut axis (BGA), that involves both the afferent-ascending and the efferent-descending pathways, as well as the somatosensory cortex, insula, amygdala, anterior cingulate cortex, and hippocampus, are deranged in IBS showing both the activation and inactivation. Clinical manifestations of IBS such as pain, altered gut motility, and psychological dysfunction may each be explained, in part, through the changes in the BGA, but there is conflicting information, and its precise role is not fully understood. A better understanding of the BGA may shed more knowledge regarding the pathophysiology of IBS that in turn may lead to the discovery of novel therapies for this common disorder.

Entities:  

Mesh:

Year:  2014        PMID: 24595616      PMCID: PMC4083372          DOI: 10.1007/s11894-014-0379-z

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  65 in total

Review 1.  The neurobiology of stress and gastrointestinal disease.

Authors:  E A Mayer
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Sex differences of brain serotonin synthesis in patients with irritable bowel syndrome using alpha-[11C]methyl-L-tryptophan, positron emission tomography and statistical parametric mapping.

Authors:  Akio Nakai; Yoshikata Kumakura; Michel Boivin; Pedro Rosa; Mirko Diksic; Doreen D'Souza; Kathryn Kersey
Journal:  Can J Gastroenterol       Date:  2003-03       Impact factor: 3.522

Review 3.  Neurohumoral control of gastrointestinal motility.

Authors:  M B Hansen
Journal:  Physiol Res       Date:  2003       Impact factor: 1.881

4.  Visceral afferent hypersensitivity in irritable bowel syndrome--evaluation by cerebral evoked potential after rectal stimulation.

Authors:  P Sinhamahapatra; S P Saha; A Chowdhury; S K Chakrabarti; A Ghosh; B Maiti
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

5.  Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome.

Authors:  Mats B O Larsson; Kirsten Tillisch; A D Craig; Maria Engström; Jennifer Labus; Bruce Naliboff; Peter Lundberg; Magnus Ström; Emeran A Mayer; Susanna A Walter
Journal:  Gastroenterology       Date:  2011-11-19       Impact factor: 22.682

6.  Distinct neurophysiological profiles in irritable bowel syndrome.

Authors:  Naila Arebi; Dominic C Bullas; George E Dukes; Salma Gurmany; Kirsty J Hicks; Michael A Kamm; Anthony R Hobson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

7.  Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention.

Authors:  H Mertz; V Morgan; G Tanner; D Pickens; R Price; Y Shyr; R Kessler
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

Review 8.  Interactions between NPY and CRF in the amygdala to regulate emotionality.

Authors:  Tammy J Sajdyk; Anantha Shekhar; Donald R Gehlert
Journal:  Neuropeptides       Date:  2004-08       Impact factor: 3.286

9.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.

Authors:  L W Swanson; P E Sawchenko; J Rivier; W W Vale
Journal:  Neuroendocrinology       Date:  1983       Impact factor: 4.914

10.  Neuromodulatory processes of the brain-gut axis.

Authors:  Alexandru Gaman; Braden Kuo
Journal:  Neuromodulation       Date:  2008-10-01
View more
  30 in total

Review 1.  Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity.

Authors:  Pasquale Mansueto; Alberto D'Alcamo; Aurelio Seidita; Antonio Carroccio
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

2.  Activation of 5-HT and NR2B contributes to visceral hypersensitivity in irritable bowel syndrome in rats.

Authors:  Ming-Xian Chen; Yu Chen; Rui Fu; Sai-Yue Liu; Qin-Qin Yang; Tang-Biao Shen
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

3.  Acute recurrent bradycardia with evoked potential loss during transforaminal lumbar interbody fusion.

Authors:  C P Schwan; M R Pedersen; K Tavanaiepour; D Tavanaiepour; A L Hoefnagel; P D Mongan
Journal:  Anaesth Rep       Date:  2020-06-19

4.  Irritable Bowel Syndrome.

Authors:  Kristen Ronn Weaver; Gail DʼEramo Melkus; Wendy A Henderson
Journal:  Am J Nurs       Date:  2017-06       Impact factor: 2.220

5.  Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial.

Authors:  Vladimir T Ivashkin; Anna V Kudryavtseva; George S Krasnov; Yuri M Poluektov; Margarita A Morozova; Oleg S Shifrin; Allan G Beniashvili; Zarina A Mamieva; Alexandra L Kovaleva; Anatoly I Ulyanin; Elizaveta A Trush; Alexander G Erlykin; Elena A Poluektova
Journal:  PLoS One       Date:  2022-06-15       Impact factor: 3.752

Review 6.  Diagnosis and management of chronic constipation in adults.

Authors:  Satish S C Rao; Kulthep Rattanakovit; Tanisa Patcharatrakul
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-01       Impact factor: 46.802

Review 7.  Aspects of the non-pharmacological treatment of irritable bowel syndrome.

Authors:  Elsa Maria Eriksson; Kristina Ingrid Andrén; Göran Karl Kurlberg; Henry Ture Eriksson
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

8.  Vagus nerve assessment via ultrasonography in irritable bowel syndrome. Are there any changes of dimension in the vagus nerve?

Authors:  Ömer Özçağlayan; Tuğba İlkem Kurtoğlu Özçağlayan; Mücahit Doğru; Rafet Mete
Journal:  Turk J Gastroenterol       Date:  2020-07       Impact factor: 1.852

9.  Lorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical Trial.

Authors:  Olivia M Farr; Jagriti Upadhyay; Anna Gavrieli; Michelle Camp; Nikolaos Spyrou; Harper Kaye; Hannah Mathew; Maria Vamvini; Anastasia Koniaris; Holly Kilim; Alexandra Srnka; Alexandra Migdal; Christos S Mantzoros
Journal:  Diabetes       Date:  2016-07-06       Impact factor: 9.461

10.  Is Henoch-Schönlein purpura a susceptibility factor for functional gastrointestinal disorders in children?

Authors:  Rabia Miray Kisla Ekinci; Sibel Balcı; Okkes Ozgur Mart; Gokhan Tumgor; Sibel Yavuz; Halil Celik; Dilek Dogruel; Derya Ufuk Altintas; Mustafa Yilmaz
Journal:  Rheumatol Int       Date:  2018-08-12       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.